Literature DB >> 34318388

Trends and complications associated with acute new-onset heart failure: a National Readmissions Database-based cohort study.

Tanveer Mir1, Mohammed Uddin2, Waqas T Qureshi3, Layla Shanah2, Ayman Soubani2, Ghulam Saydain2, Luis Afonso2, Sheikh Mujeeb4.   

Abstract

Literature regarding recent trends and outcomes of acute new-onset heart failure (AHF) with preserved ejection fraction (AHFpEF) and reduced ejection fraction (AHFrEF) is limited. The objective of this study is to study the outcomes of AHFpEF and AHFrEF in the USA. Data from the National Readmissions Database (NRD) sample that constitutes 49.1% of the stratified sample of all hospitals in the USA, representing more than 95% of the national population, were analyzed for hospitalization visits for acute heart failure. ICD-9 and ICD-10 codes were used to identify AHF. A total of 2,559,102 adult index AHF patients (mean age 70.79 ± 14.58 years, 49.4% females), 1,028,970 (40.2%) AHFpEF and 1,330,999 (52%) AHFrEF, were recorded in the National Readmissions Database for the years 2016-2018. A total of 152,465 (5.96%) acute heart failure, 47,271 (4.6%) AHFpEF and 91,973 (6.91%) AHFrEF, died during hospitalization, and 45,810 (1.9%) were readmitted in 30 days among alive discharges. Higher complication rates which included ventricular arrhythmias, acute coronary, and cerebrovascular events were observed among AHFrEF than AHFpEF. Higher proportion of patients with AHFrEF needed intensive care unit and ventilatory support during the hospitalization. The trend of incidence of AHFrEF, mortality among AHFrEF, and overall mortality worsened while AHFpEF improved over the study years 2012-2018 (p-trend < 0.05). Coronary procedures improved mortality rates among AHFpEF and AHFrEF. AHF is very common and is associated with significant mortality. The incidence of AHFrEF and mortality among AHFrEF had worsened, which calls for urgent intervention. Improved recognition of AHF is needed, and guideline-directed treatment of underlying risk factors including coronary artery disease can improve mortality. Graphic abstract of the analysis presented (created with BioRender.com).
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acute heart failure; Acute heart failure with preserved ejection fraction; Acute heart failure with reduced ejection fraction; HFpEF; HFrEF; Mortality trends

Mesh:

Year:  2021        PMID: 34318388     DOI: 10.1007/s10741-021-10152-3

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  1 in total

1.  Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction.

Authors:  Fotini Kalogirou; Faye Forsyth; Martha Kyriakou; Rhys Mantle; Christi Deaton
Journal:  ESC Heart Fail       Date:  2020-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.